Non-small-cell lung cancer (NSCLC) is characterized by
high invasiveness,
poor prognosis, and a high mortality rate. Single radiotherapy (RT)
is ineffective in the treatment of NSCLC due to radio-resistance.
Therefore, photothermal therapy (PTT) in combination with RT has been
proposed, and PTT–RT synergistic therapy has been extensively
explored for feasible cancer treatment. In this study, targeted Au
nanoclusters embedded in polydopamine (AuNC/PDA–RGD) was constructed
for PTT–RT combined therapy of NSCLC. The AuNC/PDA was prepared
based on a one-pot seedless coassembly strategy. In the reaction,
HAuCl4 was directly reduced by dopamine to form the gold
(Au) core, and dopamine was oxidized and spontaneously self-polymerized
to form a PDA shell encapsulating the Au core. After modification
with an active targeted Arg-Gly-Asp (RGD) peptide, AuNC/PDA–RGD
was obtained, which showed good colloidal stability and low cytotoxicity.
This nanosystem could be actively taken up by NSCLC (i.e., A549) cells
via the RGD peptide-mediated internalization. Based on the high photothermal
conversion capability of AuNC/PDA and the strong radiosensitivity
of Au, the AuNC/PDA–RGD could be used for hyperthermia-synergized
RT. The in vitro and in vivo experiments showed that the constructed
nanosystem had an enhanced curative effect for the treatment of NSCLC
by integrating PTT and RT compared with monotherapy. Our studies demonstrated
that this AuNC/PDA–RGD nanoplatform has promising medical applications
in cancer therapy.